Immunomic Therapeutics
MD - RockvilleBiotechnology
Focus: Immunomic Therapeutics is a biotechnology company focused on vaccine development using Lysosomal Associated Membrane Protein (LAMP) technology, headquartered in Rockville, MD. The company operates in the infectious diseases and vaccines segment with a specialized platform approach.
Profile data last refreshed 20h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Immunomic Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Immunomic Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
8 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
CryJ2-DNA-LAMP plasmid vaccine by intramuscular injection
Allergic RhinoconjunctivitisClinical Trials (1)
NCT01966224A Safety and Immunogenicity Phase IB Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid Assessing the Long Term Safety of Previously Treated Subjects
Phase 1Help build intelligence for Immunomic Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.